NBI: The Role of Narrow Band Imaging Videobronchoscopy in Lung Cancer
Study Details
Study Description
Brief Summary
Narrow band imaging (NBI) videobronchoscopy is an optical technique in which filtered light enhances superficial neoplasm based on their neoangiogenic pattern. The objectives of this study investigate its better diagnostic yield in the assessment of lung cancer than conventional flexible bronchoscopy.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
Inspection with high resolution endoscopy was followed by NBI. Detected lesions were biopsied. applied the system of shibuya et al. to analyze and classify vascular patterns by NBI into four categories (spiral and screw pattern, dotted pattern, tortuous pattern, avascular pattern) compared with the known diagnostic yield of conventional white light bronchoscopy, An equivalent or superior result will also significantly impact on patient care This technology could aid not only early-stage lung cancer diagnosis but also more accurate local staging of lung cancer.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
lung cancer
|
Outcome Measures
Primary Outcome Measures
- accuracy of NBI videobronchoscopic biopsy [10-11 months]
Define and compare the sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio and accuriacies for the diagnostic techniques for lung cancer.
Secondary Outcome Measures
- early cancer lesion detection rate using Shibuya descriptors [10-11 months]
Define and compare the sensitivity, specificity, positive predictive value, negative predictive value, likelihood ratio and accuriacies for the diagnostic techniques for early lung cancer.
Eligibility Criteria
Criteria
Inclusion Criteria:
- endobronchial lesion on chest CT
Exclusion Criteria:
-
Age < 18 years old
-
Inability to consent for the study
-
Inability to tolerate bronchoscopy
-
Active pulmonary infection (bronchitis, pneumonia)
-
ST elevation or depression on ECG
-
Prothrombin time prolongation(<70%)
-
platelet <10,000
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | ChangMin, Choi | Seoul | Korea, Republic of |
Sponsors and Collaborators
- Asan Medical Center
Investigators
- Principal Investigator: ChangMin Choi, M.D., Asan Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- NBI-AMC